Searchable abstracts of presentations at key conferences in endocrinology

ea0037gp.29.05 | Endocrine tumours and neoplasia – Adrenal Tumour | ECE2015

EGFR as potential new molecular target in the medical treatment of adrenocortical cancer

Gagliano Teresa , Balboni Francesco , Pasquale Carmelina Di , Gentilin Erica , Benfini Katiusci , Falletta Simona , Bondanelli Marta , Franceschetti Paola , Feo Carlo , Uberti Ettore degli , Zatelli Maria Chiara

Adrenocortical cancer (ACC) is a rare and aggressive malignancy. Currently the main therapeutic option is surgery, but due to difficult and delayed diagnosis and to the onset of metastases, medical therapy is often tried. ACC treatment is mainly represented by Mitotane alone or in association with chemotherapy, with variable results. Understanding the molecular mechanisms that regulate ACC proliferation could be useful to identify new therapeutic options. Sunitinib, a multitar...

ea0037ep868 | Thyroid cancer | ECE2015

Role of miR-26a in follicular thyroid carcinoma

Gentilin Erica , Ortolan Elisa , Gagliano Teresa , Pasquale Carmelina Di , Falletta Simona , Rossi Roberta , Benfini Katiuscia , Tagliati Federico , Uberti Ettore Degli , Zatelli Maria Chiara

Follicular thyroid carcinoma (FTC) is the second most common thyroid malignant epithelial tumor. It is clinically asymptomatic, usually represented by a single nodule, less often multiple, with origin from thyroid follicular epithelial cells. Despite its well-differentiated characteristics, FTC may develop distant metastases through hematogenous dissemination. The molecular alterations involved in the pathogenesis of follicular neoplasia are not completely known. Recent studie...

ea0037ep1097 | Endocrine tumours | ECE2015

The sensitising action of a TIM16 inhibitor towards chemotherapeutic agents in human breast cancer cells depends on TIM16 expression

Gagliano Teresa , Tagliati Federico , Riva Eleonora , Zerbini Denise , Sambugaro Silvia , Gentilin Erica , Falletta Simona , Benfini Katiuscia , Pasquale Carmelina Di , Trapella Claudio , Salvadori Severo , Uberti Ettore degli , Zatelli Maria Chiara

TIM16 a component of the translocase complex TIM23 of the mitochondrial inner membrane is encoded by the Magmas gene. Magmas was found to be over-expressed in human pituitary adenomas. Silencing Magmas in ACTH secreting rat pituitary adenoma cells enhances sensitivity to pro-apoptotic stimuli. Moreover, Magmas overexpression protects GH secreting rat pituitary adenoma cell lines towards apoptosis. Recently, we found that compound 5, a TIM16 inhibitor, is not cytotoxic but enha...